Published in Genet Test on January 01, 1998
Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol (1998) 2.55
Genetic screening: marvel or menace? Science (1984) 1.78
Genetic counseling for beta-thalassemia trait following health screening in a health maintenance organization: comparison of programmed and conventional counseling. Am J Hum Genet (1981) 1.44
Screening and genetic counseling for beta-thalassemia trait in a population unselected for interest: effects on knowledge and mood. Am J Hum Genet (1979) 1.39
Women's receptivity to testing for a genetic susceptibility to breast cancer. Am J Public Health (1995) 1.35
Newborn screening for hemoglobinopathies in New York State: experience of physicians and parents of affected children. J Pediatr (1982) 1.35
Improving physicians' HIV risk-assessment skills using announced and unannounced standardized patients. J Gen Intern Med (2001) 1.16
Does physician uncertainty affect patient satisfaction? J Gen Intern Med (1988) 1.16
Prenatal screening for hemoglobinopathies. II. Evaluation of counseling. Am J Hum Genet (1991) 1.13
Screening and genetic counseling for beta-thalassemia trait in a population unselected for interest: comparison of three counseling methods. Am J Hum Genet (1984) 1.13
Molecular genetic analysis of tumors in von Recklinghausen neurofibromatosis: loss of heterozygosity for chromosome 17. Genes Chromosomes Cancer (1989) 1.13
Anhidrotic ectodermal dysplasia: predisposition to bronchial disease. Ann Intern Med (1971) 1.12
Induction of -globin synthesis in the -thalassaemia of Ferrara. Nat New Biol (1972) 1.08
Inducers of erythroid differentiation in K562 human leukemia cells. Exp Hematol (1981) 1.07
Erythroid colony formation from human fetal liver. Proc Natl Acad Sci U S A (1978) 1.06
Feasibility of large-scale cholesterol screening: experience with a portable capillary-blood testing device. Am J Public Health (1987) 1.03
Cystic fibrosis carrier population screening in the primary care setting. Am J Hum Genet (1996) 1.02
Prenatal hemoglobinopathy screening. IV. Follow-up of women at risk for a child with a clinically significant hemoglobinopathy. Am J Hum Genet (1991) 1.01
Newborn sickle cell screening. Benefits and burdens realized. Am J Dis Child (1983) 0.96
Genetic counseling of asymptomatic carriers in a primary care setting. The effectiveness of screening and counseling for beta-thalassemia trait. Ann Intern Med (1986) 0.94
Hemoglobin synthesis in cultures of hepatic erythroid cells from the human fetus. Proc Natl Acad Sci U S A (1979) 0.94
Family issues in a psychoeducation group for women with a BRCA mutation. Clin Genet (2002) 0.91
Recruitment using mass media strategies. Circulation (1982) 0.89
Distinction between two types of beta-thalassaemia by inducibility of the cell-free synthesis of beta-chains by nonthalassaemic soluble fraction. Nat New Biol (1972) 0.89
Separation of malarial parasites according to age by density gradient centrifugation. J Lab Clin Med (1967) 0.89
Use of stage of change (SOC) to develop an STD/HIV behavioral intervention: phase 1. A system to classify SOC for STD/HIV sexual risk behaviors--development and reliability in an STD clinic. AIDS Patient Care STDS (1999) 0.89
Protein synthesis in the maturing reticulocyte. J Biol Chem (1967) 0.89
Multipotent human hematopoietic cell line K562: lineage-specific constitutive and inducible antigens. Leuk Res (1987) 0.88
Using patient instructors to teach behavioral counseling skills. J Med Educ (1987) 0.87
Newborn screening for sicle-cell disease. Benefits and burdens. N Y State J Med (1978) 0.86
The neurofibroma in von Recklinghausen neurofibromatosis has a unicellular origin. Am J Hum Genet (1991) 0.86
Cystic fibrosis carrier screening: knowledge and attitudes of prenatal care providers. Am J Prev Med (1994) 0.86
Protein synthesis in reticulocytes maturing in vivo. Nature (1965) 0.86
Carrier screening for cystic fibrosis: test acceptance and one year follow-up. Am J Med Genet (1997) 0.86
Erythroleukemia manifesting delta beta-thalassemia. Hemoglobin (1983) 0.85
Pathogenesis of deficient serum alpha1-antitrypsin in the type ZZ homozygote. Biochem Genet (1974) 0.85
An adult homozygous for persistent fetal hemoglobin. Ann Intern Med (1970) 0.85
Alveolar cell carcinoma in identical twins. Similarity in time of onset, histochemistry, and site of metastasis. Ann Intern Med (1977) 0.85
Regulation of K562 cell transferrin receptors by exogenous iron. J Cell Physiol (1985) 0.84
A Lepore hemoglobin in a Rumanian family. Hum Hered (1969) 0.84
Sickle hemoglobin: a specific radioimmunoassay. Blood (1974) 0.84
Toward providing parents the option of avoiding the birth of the first child with Cooley's anemia: response to hemoglobinopathy screening and counseling during pregnancy. Ann N Y Acad Sci (1985) 0.84
The diagnosis of beta-thalassemia trait: a review. Am J Hematol (1976) 0.84
Linkage between the MN- and Hb beta-loci? Hum Hered (1972) 0.84
Incorporation of screening and genetic counseling for beta-thalassemia trait into primary health care: effects on knowledge and attitudes. Birth Defects Orig Artic Ser (1982) 0.83
Hemoglobin S-C disease presenting as acute cor pulmonale. Am Rev Respir Dis (1968) 0.83
Acquired hemoglobin H disease in idiopathic myelofibrosis. Am J Hematol (1979) 0.82
Solubilization of a reticulocyte ribosomal fraction responsible for the decline in ribosomal activity with cell maturation. Arch Biochem Biophys (1971) 0.81
K562 human leukemia cell passages differ in embryonic globin gene expression. Leuk Res (1984) 0.81
K562 human erythroleukemia cells demonstrate commitment. Blood (1985) 0.81
Predicting immediate outcome of genetic counseling following screening. Soc Biol (1979) 0.80
The linkage relationships of the haemoglobin beta, delta and alpha loci with 34 genetic marker systems. Ann Hum Genet (1977) 0.80
Modifying the Type A coronary-prone behavior pattern. J Consult Clin Psychol (1983) 0.80
Induction of megakaryocytic characteristics in human leukemic cell line K562: polyploidy, inducers, and secretion of mitogenic activity. J Biol Regul Homeost Agents (1988) 0.80
Oncogene expression in neurofibromatosis. Ann N Y Acad Sci (1986) 0.80
Human lymphocyte telomerase is genetically regulated. Genes Chromosomes Cancer (1998) 0.79
Cystic fibrosis carrier population screening: a review. Genet Test (1997) 0.79
Hemin preferentially stimulates synthesis of alpha-globin in K562 human erythroleukemia cells. Blood (1982) 0.79
Telomere-related components are coordinately synthesized during human T-lymphocyte activation. Leuk Res (1999) 0.79
High resolution analysis of hemoglobins: polyacrylamide isoelectric focusing. Biochem Med (1972) 0.79
Tumor suppressor genes and inherited predisposition to malignancy. Semin Oncol (1989) 0.78
Serm alpha-antitrypsin types: elastase inhibition versus trypsin inhibition. Hum Hered (1974) 0.78
Comparison of established and innovative weight-reduction treatment procedures. J Appl Behav Anal (1979) 0.78
Hereditary haemorrhagic telangiectasia: aggravation by oral contraceptives? Lancet (1970) 0.77
Serum antitrypsin synthesis by the isolated perfused rat liver. Proc Soc Exp Biol Med (1975) 0.77
Induction of HL60 cell differentiation by tiazofurin and its analogues: characterization and efficacy. Blood (1991) 0.77
Disappearance of ribosomes and polyribosomes during in vivo erythroid maturation. Nature (1967) 0.77
Demonstration of commitment by K562 human erythroleukemia cells. Prog Clin Biol Res (1985) 0.77
Sickle beta-thalassemia: identical twins differing in severity implicate nongenetic factors influencing course. Am J Hematol (1976) 0.76
Regulation of the activity of heme degradative enzymes in K562 erythroleukemic cells: induction by thymidine. Exp Hematol (1987) 0.76
Characteristics of the antitrypsin activity of human serum. J Clin Pathol (1973) 0.75
Confusion about breast-cancer screening. N Engl J Med (1997) 0.75
Residents' counseling skills. J Gen Intern Med (1991) 0.75
Prenatal screening for hemoglobinopathies. Am J Hum Genet (1991) 0.75
K562 human erythroleukemia cell variants resistant to growth inhibition by butyrate have deficient histone acetylation. Am J Hum Genet (1984) 0.75
Genetic considerations in neuromuscular diseases. Adv Neurol (1977) 0.75
Single-cell analysis of the relationship among transferrin receptors, proliferation, and cell cycle phase in K562 cells. Cytometry (1985) 0.75
Familial hearing loss associated with branchial fistulas. Pediatrics (1969) 0.75
Sickle cell trait/hereditary persistence of fetal hemoglobin trait. Misdiagnosis as sickle cell anemia by newborn screening. Am J Dis Child (1979) 0.75
Deleterious mutations of both BRCA1 and BRCA2 in three siblings. Genet Test (1998) 0.75
Issues in implementing prenatal screening for cystic fibrosis: results of a working conference. Genet Med (2001) 0.75
Textural differences between AA and SS blood specimens as detected by image analysis. Cytometry (1994) 0.75
Hospitalization as an opportunity to improve hypertension recognition and control. Med Care (1987) 0.75
Erythroid induction of K562 human leukemia cells: enhancement by purines. Arch Biochem Biophys (1985) 0.75
What you should know about chromosome analysis. Alaska Med (1969) 0.75
Erythroid differentiation of K562 cells: mixed colonies as an index of delayed expression of commitment. Exp Hematol (1987) 0.75
Letter: Family history-taking. J Med Educ (1976) 0.75
Genetic screening: whose responsibility? JAMA (1976) 0.75
Enhanced polyribosome recovery from reticulocytes using heparin. Exp Cell Res (1967) 0.75
Critical clinical issues in the behavioral treatment of obesity. Addict Behav (1979) 0.75
Hypersplenic thrombocytopenia in sickle cell-bata thalassemia. Am J Med Sci (1972) 0.75
Genetic counseling in medical practice. Alaska Med (1969) 0.75
K562 cell erythroid differentiation: requirement for a factor in fetal bovine serum. Exp Hematol (1985) 0.75
Genetics for the cardiologist. Part II: Chromosomal and polygenic inheritance and genetic counseling. Mod Concepts Cardiovasc Dis (1978) 0.75
The contribution of red cell morphology to the diagnosis of beta-thalassemia trait. Blood Cells (1986) 0.75
Induction of hemoglobin synthesis in K562 cells by carbon dioxide deficiency. Int J Cell Cloning (1987) 0.75
Drug-sensitive hemoglobinopathies. N Engl J Med (1973) 0.75
Long survival in sickle-cell disease. Lancet (1973) 0.75